| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.47 | 0.03 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.41 | 0.06 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.4 | 0.3 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.36 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.35 | 0.07 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.3 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.28 | 0.2 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.27 | 0.3 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.26 | 0.3 |